about
Role of "old" pharmacological agents in the treatment of Cushing's syndromeUpdates on the role of adrenal steroidogenesis inhibitors in Cushing's syndrome: a focus on novel therapiesThe risks of overlooking the diagnosis of secreting pituitary adenomasUpdate on medical treatment for Cushing's disease.Long-term treatment of Cushing's disease with pasireotide: 5-year results from an open-label extension study of a Phase III trialThe Role of Isotretinoin Therapy for Cushing's Disease: Results of a Prospective Study.Algorithm development and the clinical and economic burden of Cushing's disease in a large US health plan databaseOsilodrostat, a potent oral 11β-hydroxylase inhibitor: 22-week, prospective, Phase II study in Cushing's disease.Pituitary Medicine From Discovery to Patient-Focused Outcomes.Cold inducible RNA binding protein upregulation in pituitary corticotroph adenoma induces corticotroph cell proliferation via Erk signaling pathway.Fractures in pituitary adenoma patients from the Dutch National Registry of Growth Hormone Treatment in Adults.Mifepristone Accelerates HPA Axis Recovery in Secondary Adrenal InsufficiencyInhibition of Ubiquitin-specific Peptidase 8 Suppresses Adrenocorticotropic Hormone Production and Tumorous Corticotroph Cell Growth in AtT20 Cells.Phenotype-Genotype Association Analysis of ACTH-Secreting Pituitary Adenoma and Its Molecular Link to Patient Osteoporosis.Medical Therapy with Pasireotide in Recurrent Cushing's Disease: Experience of Patients Treated for At Least 1 Year at a Single Center.Current best practice in the management of patients after pituitary surgery.Effects of the single and combined treatment with dopamine agonist, somatostatin analog and mTOR inhibitors in a human lung carcinoid cell line: an in vitro study.Is there a role for early chemotherapy in the management of pituitary adenomas?Cushing's disease: the burden of illness.Surgical outcomes in patients with Cushing's disease: the Cleveland clinic experience.Paradoxical and atypical responses to pasireotide in aggressive ACTH-secreting pituitary tumors.Currently used and investigational drugs for Cushing´s disease.Safety of transsphenoidal microsurgical approach in patients with an ACTH-secreting pituitary adenoma.Recent Progress in the Medical Therapy of Pituitary TumorsA rare case of multiple pituitary adenomas in an adolescent Cushing disease presenting as a vertebral compression fracture.Follow-up intervals in patients with Cushing's disease: recommendations from a panel of experienced pituitary clinicians.Detection of programmed death ligand 1 protein and CD8+ lymphocyte infiltration in plurihormonal pituitary adenomas: A case report and review of the literatures.Dimethoxy-etomidate: A Non-hypnotic Etomidate Analog that Potently Inhibits Steroidogenesis.Paraneoplastic Cushing syndrome, case-series and review of the literature.The degree of urinary hypercortisolism is not correlated with the severity of cushing's syndrome.A lack of day-by-day variability in blood pressure in a Cushing's disease patient.A polymorphism in the CYP17A1 gene influences the therapeutic response to steroidogenesis inhibitors in Cushing's syndrome.Does pasireotide directly modulate skeletal muscle metabolism?Glucocorticoid Signaling in Health and Disease: Insights From Tissue-Specific GR Knockout Mice.Impact of Adrenal Steroids on Regulation of Adipose Tissue.Pituitary gland: Gamma Knife for Cushing disease - time for a reappraisal?Posaconazole-Induced Adrenal Insufficiency in a Case of Chronic Myelomonocytic Leukemia.Etomidate in the control of severe Cushing's syndrome by neuroendocrine carcinoma.New Insights in Cushing Disease Treatment With Focus on a Derivative of Vitamin A.Diabetes Mellitus Secondary to Cushing's Disease.
P2860
Q28067685-EEEB2797-1B82-439F-9657-7FA8E6D0066BQ28076013-DAC6FA0C-49DF-425F-A5BD-3ED58DD7C36EQ28076665-7CC694A2-10D3-4D41-B569-6EF20184D97AQ33802284-69624795-B188-42D1-9423-35680105535EQ33840655-55AA846E-D5D9-49A9-82F3-988445DBA225Q36681083-B9BE97E1-5834-49F4-BCA9-50399BE018A9Q36704444-8DC005B4-8451-465B-B06A-445799CD3341Q36704499-83B70D08-8259-44B7-9939-FA91C38A06AEQ36716025-0C3058F4-768C-45D2-9B7A-D555649C5054Q36962542-314E0B8E-CDAD-4288-B627-11E4CAF42A0DQ37072338-9BA82313-CC1F-49DE-BED7-2C5AE49F41BEQ37144269-6846508E-4683-42FC-A907-2434A8BEDE41Q37228518-D8390CEF-0809-4745-B422-030854FD7DBBQ37377304-59C65CBD-8E91-4E1A-9B31-912F637DF2A0Q37667713-4D998E5A-ACD8-4533-A6FF-3E86178E0FB4Q37718163-929F5FB6-5C12-49FC-A337-28ABBAE7E610Q38743093-17AEB8CD-01F9-4DAF-A149-FF573BD6A59DQ38815400-32710D79-9197-4A69-8D06-8311EA2B572AQ38836721-12CFFE88-350D-412B-9954-9388A65F8C73Q38925788-D824868F-A908-4167-9575-0CBC1621BF34Q38957573-7B0A8F65-B4E4-4DA3-AB14-E009038826E9Q39022297-99545F7C-4A64-4C7A-B1C3-88FAC76B48C9Q39074559-6A7FB12B-2162-4D09-8D0F-3A0FC9617408Q39420116-6E91CB51-3875-421E-BD1D-1C43FE09DC9DQ42378175-E80E590B-F83A-49B9-A6B1-EE99A1B03801Q46644513-0B5B47CA-79AE-48C2-AD75-EA7DCF2C8D6EQ47130162-49D26E27-3A43-43A7-B539-5FDCEA30B118Q47224599-ADA3F595-53C1-43AF-B673-A452301A9801Q47775730-016627E7-3147-406B-AFAD-E498165358A3Q47859835-C5DF925E-B12F-42FC-96C5-9901F7229BB1Q48088647-1461AFCF-802B-45B7-949F-4B2099A4A81AQ48194404-BB840E33-CCAE-4503-865B-9D54D62D2E00Q48307756-7DBA1409-ED09-4CD4-BDE7-F5D4ABEBD753Q50065331-B465D353-53B8-49EC-9943-14253531438FQ50068164-D4F44339-4D0E-451C-A970-D1C25FF9B9F8Q50092580-3ED5C82A-A369-4757-9AA1-EE8F1831796BQ54250335-FE024B52-24CE-41CB-AD4A-C3908035B5D8Q55002339-CC97F5E9-2A5C-4E79-B574-074AD4B9290CQ55249109-F7BCC54E-F391-4402-AC58-54BFEDE7FF93Q55425212-7419FC7A-14D9-4F26-96AE-9870EACF7E3D
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The Treatment of Cushing's Disease
@nl
The Treatment of Cushing's Disease.
@ast
The Treatment of Cushing's Disease.
@en
type
label
The Treatment of Cushing's Disease
@nl
The Treatment of Cushing's Disease.
@ast
The Treatment of Cushing's Disease.
@en
prefLabel
The Treatment of Cushing's Disease
@nl
The Treatment of Cushing's Disease.
@ast
The Treatment of Cushing's Disease.
@en
P2860
P3181
P356
P1433
P1476
The Treatment of Cushing's Disease.
@en
P2093
Alessia Cozzolino
Monica De Leo
P2860
P304
P3181
P356
10.1210/ER.2013-1048
P407
P577
2015-06-11T00:00:00Z